Tom L Van Belle

Tom L Van Belle

UNVERIFIED PROFILE

Are you Tom L Van Belle?   Register this Author

Register author
Tom L Van Belle

Tom L Van Belle

Publications by authors named "Tom L Van Belle"

Are you Tom L Van Belle?   Register this Author

15Publications

241Reads

41Profile Views

Dietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in NOD mice when given early and long term.

Diabetes 2014 Jun 18;63(6):2026-36. Epub 2014 Feb 18.

Clinical and Experimental Endocrinology (CEE), Department of Clinical and Experimental Medicine, Katholieke Universiteit Leuven, Campus Gasthuisberg, Leuven, Belgium

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db13-1559DOI Listing
June 2014

1,25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice.

J Immunol 2014 May 24;192(9):4210-20. Epub 2014 Mar 24.

Laboratory of Clinical and Experimental Endocrinology, Katholieke Universiteit Leuven, 3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1302350DOI Listing
May 2014

Vitamin D and diabetes: the odd couple.

Trends Endocrinol Metab 2013 Nov 21;24(11):561-8. Epub 2013 Aug 21.

Clinical and Experimental Endocrinology, Katholieke Universiteit (KU) Leuven, Campus Gasthuisberg, O&N 1 Herestraat 49, Box 902, 3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10432760130012
Publisher Site
http://dx.doi.org/10.1016/j.tem.2013.07.002DOI Listing
November 2013

NKG2D blockade facilitates diabetes prevention by antigen-specific Tregs in a virus-induced model of diabetes.

J Autoimmun 2013 Feb 1;40:66-73. Epub 2012 Sep 1.

Type 1 Diabetes Center of San Diego, La Jolla Institute for Allergy and Immunology, La Jolla, 9420 Athena Circle, San Diego, CA 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2012.08.001DOI Listing
February 2013

IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells.

PLoS One 2012 20;7(9):e45299. Epub 2012 Sep 20.

Laboratory of Molecular Immunology, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0045299PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447928PMC
February 2013

Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets.

Immunity 2012 Jun 10;36(6):1060-72. Epub 2012 May 10.

Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2012.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810457PMC
June 2012

Development of autoimmune diabetes in the absence of detectable IL-17A in a CD8-driven virally induced model.

J Immunol 2011 Sep 10;187(6):2915-22. Epub 2011 Aug 10.

Diabetes Center of San Diego, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1000180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169711PMC
September 2011

Vitamin D in autoimmune, infectious and allergic diseases: a vital player?

Best Pract Res Clin Endocrinol Metab 2011 Aug;25(4):617-32

Laboratory for Experimental Medicine and Endocrinology, Catholic University Leuven, Herestraat 49, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beem.2011.04.009DOI Listing
August 2011

Type 1 diabetes: etiology, immunology, and therapeutic strategies.

Physiol Rev 2011 Jan;91(1):79-118

Center for Type 1 Diabetes Research, La Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/physrev.00003.2010DOI Listing
January 2011

Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment.

J Autoimmun 2010 Jun 9;34(4):445-52. Epub 2009 Dec 9.

Diabetes Center at San Diego, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2009.11.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860005PMC
June 2010

The role of the activating receptor NKG2D in autoimmunity.

Mol Immunol 2009 Nov 14;47(1):8-11. Epub 2009 Mar 14.

Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2009.02.023DOI Listing
November 2009